FDA Recalls Finder

FDA Approves Opioid Pain Reliever with Required Risk Reduction Plan
   

Thu, 16 Jul 2009 16:05:00 UTC
   
The U.S. Food and Drug Administration today approved Onsolis, medication intended for certain patients with cancer to help manage breakthrough pain – severe flares of pain that break through regular pain medication.
   
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm172366.htm